National Cancer Institute (NCI)
Bethesda, Maryland, 20892, United States
NCT Number: NCT00001164
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.
Looking for future studies?
Notify MeAll sexes
Observational
Bethesda, Maryland, 20892, United States
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Patients with skin diseases of presumed genetic, immunologic, or virologic origin are eligible.
Patients with neurological degenerations are eligible, including patients with inflammatory, neoplastic and viral skin diseases and also heterozygous carriers of such inherited diseases.
Volunteers without skin diseases are eligible, except children.
National Cancer Institute (NCI)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05050682
COVID-19, Coronaviridae Infections
Madison, Wisconsin, United States
View Trial DetailsNCT04472546
Acne, Acne Vulgaris
Toulouse, France
View Trial DetailsNCT03986671
Amyotrophic Lateral Sclerosis, Apnea
San Diego, California, United States
View Trial DetailsNCT01539213
Dermatitis, Healthy
Graz, Austria
View Trial Details